Literature DB >> 3396217

IgG subclass composition of antibodies to HBsAg in circulating immune complexes from patients with hepatitis B virus infections.

S Rath1, M E Devey.   

Abstract

The IgG subclass of antibody associated with hepatitis B surface antigen (HBsAg) in circulating immune complexes (CIC) from patients with either acute or chronic hepatitis B virus (HBV) infections was measured using an isotype and antigen-specific ELISA. All patients were HBsAg positive but were negative for free anti-HBs antibody. The subclass of antibody associated with HBsAg in CIC in both groups was predominantly IgG1 and IgG4. This is in contrast to free anti-HBs in convalescent sera from patients recovering from HBV infection, which are highly restricted to IgG1 and IgG3. The finding of high levels of IgG4 antibodies in CIC suggest that CIC containing this subclass may be cleared less efficiently than CIC containing antibodies of other subclasses. Formation of these CIC may be an important factor in the progression of infection to chronicity and may also be involved in the antigen-specific immunosuppression seen in early acute and chronic HBV infections.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396217      PMCID: PMC1541492     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization.

Authors:  M E Devey; D V Wilson; A W Wheeler
Journal:  Clin Allergy       Date:  1976-05

2.  Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy.

Authors:  M van der Giessen; W L Homan; G van Kernbeek; R C Aalberse; P H Dieges
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

3.  Prominence of IgG4 in the IgG antibody response to human filariasis.

Authors:  E A Ottesen; F Skvaril; S P Tripathy; R W Poindexter; R Hussain
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

4.  The immunopathological significance of the heterogeneity of antibody affinity.

Authors:  J F Soothill; M W Steward
Journal:  Clin Exp Immunol       Date:  1971-08       Impact factor: 4.330

5.  The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses.

Authors:  A B Parkes; S M McLachlan; P Bird; B Rees Smith
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

6.  Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.

Authors:  R C Aalberse; R van der Gaag; J van Leeuwen
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

7.  IgG subclasses of anti-HBs antibodies in vaccinated and nonvaccinated individuals and in anti-HBs immunoglobulin preparations.

Authors:  F Skvaril; H Joller-Jemelka
Journal:  Int Arch Allergy Appl Immunol       Date:  1984

8.  Immunoglobulin G subclass restriction of antibodies against hepatitis B surface antigen.

Authors:  A Morell; B Roth-Wicky; F Skvaril
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Mechanisms of liver cell damage in acute hepatitis B.

Authors:  B J Mohite; S Rath; V Bal; S A Kamat; S N Marathe; A J Zuckerman; R S Kamat
Journal:  J Med Virol       Date:  1987-07       Impact factor: 2.327

10.  Chronic liver disease: the detection and characterization of circulating immune complexes.

Authors:  S E Brown; M W Steward; L Viola; C R Howard; I M Murray-Lyon
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

View more
  15 in total

1.  Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history.

Authors:  Anna P Toptygina; Alexander L Pukhalsky; Vladimir A Alioshkin
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

2.  High affinity mouse-human chimeric Fab against hepatitis B surface antigen.

Authors:  Biplab Bose; Navin Khanna; Subrat K Acharya; Subrata Sinha
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

3.  Generation and characterization of high affinity humanized fab against hepatitis B surface antigen.

Authors:  Ashutosh Tiwari; Durgashree Dutta; Navin Khanna; Subrat K Acharya; Subrata Sinha
Journal:  Mol Biotechnol       Date:  2009-03-27       Impact factor: 2.695

4.  Immunoglobulin G subclass antibodies to measles virus in patients with subacute sclerosing panencephalitis or multiple sclerosis.

Authors:  P D Mehta; B A Patrick; W Sobczyk; J Kulczycki; J Woyciechowska-Camenga; D Camenga; H Thormar
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

Review 5.  The humoral immune response in acute and chronic hepatitis B virus infection.

Authors:  D R Milich; M Sallberg; T Maruyama
Journal:  Springer Semin Immunopathol       Date:  1995

6.  The serology of chronic hepatitis B infection revisited.

Authors:  T Maruyama; A McLachlan; S Iino; K Koike; K Kurokawa; D R Milich
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

7.  IgG subclasses in circulating immune complexes with hepatitis B e antigen in chronic hepatitis B.

Authors:  M Sällberg; H Norder; G Lindh; L O Magnius
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

8.  Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus.

Authors:  K Madalinski; B Burczynska; K H Heermann; A Uy; W H Gerlich
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

9.  Induction of IgA and sustained deficiency of cell proliferative response in chronic hepatitis C.

Authors:  Yalena Amador-Cañizares; Liz Alvarez-Lajonchere; Ivis Guerra; Ingrid Rodríguez-Alonso; Gillian Martínez-Donato; Julián Triana; Eddy E González-Horta; Angel Pérez; Santiago Dueñas-Carrera
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

10.  Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion.

Authors:  Tamako Garcia; Jisu Li; Camille Sureau; Kiyoaki Ito; Yanli Qin; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.